A detailed history of Mercer Global Advisors Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Mercer Global Advisors Inc holds 170,056 shares of TAK stock, worth $2.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
170,056
Previous 209,838 18.96%
Holding current value
$2.36 Million
Previous $2.92 Million 24.53%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$12.6 - $13.67 $501,253 - $543,819
-39,782 Reduced 18.96%
170,056 $2.2 Million
Q1 2024

May 15, 2024

SELL
$13.89 - $15.04 $40,739 - $44,112
-2,933 Reduced 1.38%
209,838 $2.92 Million
Q4 2023

Feb 14, 2024

SELL
$13.36 - $15.43 $620,425 - $716,553
-46,439 Reduced 17.92%
212,771 $3.04 Million
Q3 2023

Nov 13, 2023

BUY
$15.03 - $16.32 $1.36 Million - $1.48 Million
90,669 Added 53.8%
259,210 $4.01 Million
Q2 2023

Aug 14, 2023

BUY
$15.57 - $17.11 $358,514 - $393,974
23,026 Added 15.82%
168,541 $2.65 Million
Q1 2023

May 15, 2023

BUY
$15.28 - $16.48 $210,084 - $226,583
13,749 Added 10.43%
145,515 $2.4 Million
Q4 2022

Feb 08, 2023

BUY
$12.42 - $15.62 $153,461 - $193,000
12,356 Added 10.35%
131,766 $2.06 Million
Q3 2022

Nov 15, 2022

BUY
$12.8 - $28.65 $26,995 - $60,422
2,109 Added 1.8%
119,410 $1.55 Million
Q2 2022

Aug 10, 2022

BUY
$13.12 - $15.03 $76,765 - $87,940
5,851 Added 5.25%
117,301 $1.65 Million
Q1 2022

May 10, 2022

BUY
$13.54 - $15.35 $400,377 - $453,899
29,570 Added 36.11%
111,450 $1.6 Million
Q4 2021

Feb 04, 2022

SELL
$13.17 - $16.4 $98,156 - $122,229
-7,453 Reduced 8.34%
81,880 $1.12 Million
Q3 2021

Nov 10, 2021

BUY
$16.3 - $17.26 $158,158 - $167,473
9,703 Added 12.19%
89,333 $1.46 Million
Q2 2021

Aug 10, 2021

SELL
$16.55 - $18.64 $107,210 - $120,749
-6,478 Reduced 7.52%
79,630 $1.34 Million
Q1 2021

May 11, 2021

SELL
$16.71 - $19.9 $22,825 - $27,183
-1,366 Reduced 1.56%
86,108 $1.57 Million
Q4 2020

Feb 12, 2021

SELL
$15.39 - $18.97 $43,692 - $53,855
-2,839 Reduced 3.14%
87,474 $1.59 Million
Q3 2020

Dec 10, 2020

BUY
$17.1 - $19.19 $57,712 - $64,766
3,375 Added 3.88%
90,313 $1.61 Million
Q2 2020

Aug 10, 2020

BUY
$14.59 - $19.5 $452,713 - $605,065
31,029 Added 55.5%
86,938 $1.56 Million
Q1 2020

May 18, 2020

BUY
$13.02 - $20.31 $260,452 - $406,281
20,004 Added 55.71%
55,909 $849,000
Q4 2019

Feb 13, 2020

SELL
$16.88 - $20.83 $86,915 - $107,253
-5,149 Reduced 12.54%
35,905 $708,000
Q3 2019

Nov 12, 2019

BUY
$16.15 - $17.99 $94,994 - $105,817
5,882 Added 16.72%
41,054 $706,000
Q2 2019

Aug 14, 2019

SELL
$16.58 - $20.49 $15,237 - $18,830
-919 Reduced 2.55%
35,172 $623,000
Q1 2019

Apr 23, 2019

BUY
$16.7 - $21.52 $201,819 - $260,069
12,085 Added 50.34%
36,091 $735,000
Q1 2019

Apr 12, 2019

BUY
$16.7 - $21.52 $400,900 - $516,609
24,006 New
24,006 $404,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.